泛自閉症障礙 (ASD) 的診斷和治療:全球市場
Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets
|出版日期||內容資訊||英文 162 Pages
|泛自閉症障礙 (ASD) 的診斷和治療:全球市場 Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets|
|出版日期: 2015年03月11日||內容資訊: 英文 162 Pages||
全球泛自閉症障礙 (ASD) 市場規模2013年是3億4,620萬美元，2014年是3億6,090萬美金。預計該市場今後以2.7％的年複合成長率擴大，2019年達到4億1,270萬美元。
本報告提供全球泛自閉症障礙 (ASD) 治療、診斷市場相關調查、全球與地區市場概要、實際成果資料、估計，及包含年複合成長率預測的全球市場趨勢分析、種類、流行病學、症狀、病因、病理學相關的資訊，及主要企業簡介等彙整，為您概述為以下內容。
The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.
The scope of this study encompasses the global and regional markets for therapeutic and diagnostic technologies of ASD. BCC Research analyzed each market and its applications, regulatory environment, technology, market projections and market share. Issues discussed include the major drug profiles, technological features and trends. The global markets for the ASD therapeutics and diagnostics include selected markets in the U.S., Canada, the U.K., France, Germany, Spain, Italy and Japan. The markets of the rest of the world are not reported due to their economic insignificance for this report.
This report was authored by Ufuk Ezer. Ezer holds a bachelor's degree in bioengineering and a master's degree in biotechnology, bioprocessing and business management. The analyst possesses extensive pharmaceutical research and development experience through participating projects in various international institutions and organizations. Ezer has been granted scholarships and awards during his post-study works in countries such as Japan and Panama due to his high quality of work and excellence in the fields of research.